Next, we determined whether the CCCs/SARS-CoV-2-cross-reactive epitopes were cross-recognized preferentially by the CD4+ and CD8+ T cells from either unvaccinated asymptomatic COVID-19 patients, or unvaccinated severely ill COVID-19 patients and unvaccinated patients with fatal outcomes (Supplementary Table 4). Here, CD8A is linked to COVID-19.